1Saito T, Matsunaga A, Oikawa S. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am J Kidney Dis,2006,47(2) : 199 - 211.
3Zhang B, Liu ZH, Zeng CH, et al. Clinicopathological and genetic characteristics in (Thinese patients with lipoprotein glomerulopathy.J Nephrol,2008,21(1):110-117.
4Jennette J,Olson J, Schwartz M, et al. Hepinstall' s Pat hology of the Kidney, 6th edition. Lippincott Williams & Wilkins, 2007. 1203- 1205.
4Saito T, Sato H, Kudo K, et al. Lipoprotein glomerulopa- thy.. glomerular lipoprotein thrombi in a patient with hyper-lipoproteinemia [J]. Am J Kidney Dis, 1989, 13(2).. 148-153.
5Saito T, MatsunagaA, Ito K, et al. Topics in lipoprotein glomerulopathy, an overview [J]. Clin Exp Nephrol, 2014, 18(2): 214-217.
6Konishi K, Saruta T, Kuramochi S, et al. Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy [J]. Neph- ron, 1999, 83(3): 214-218.
7Oikawa S, Matsunaga A, Saito T, et al. Apolipoprotein E sendal (Arginine 145--,Proline): A New Variant Associate with Lipoprotein Glomerulopathy [J]. J Am Soc Nephrol, 1997, 8(5): 820-823.
8Mitani A, Ishigami M, Watase K, et al. A Novel Apoli- poprotein E Mutation, APOE Osaka (Arg158 Pro), in a Dyslipidemie Patient with Lipoprotein Glomerulopathy [J]. J Atheroscler Thromb, 2011, 18(6): 531-535.
9Luo B, Huang F, Liu Q, et al. Identification of apo- lipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy [J]. Am J Nephrol, 2008, 28(2): 347-353.
10Kinomura M, Sugiyama H, Saito T, et al. A novel variant apolipoprotein E Okayama in a patient with lipoprotein glo- merulopathy [J]. Nephrol Dial Transplant, 2008, 23(2): 751-756.
